Financhill
Sell
42

JNJ Quote, Financials, Valuation and Earnings

Last price:
$152.39
Seasonality move :
0.85%
Day range:
$149.74 - $151.43
52-week range:
$140.68 - $169.99
Dividend yield:
3.32%
P/E ratio:
16.83x
P/S ratio:
4.11x
P/B ratio:
4.66x
Volume:
7.4M
Avg. volume:
8.2M
1-year change:
1.73%
Market cap:
$364.1B
Revenue:
$88.8B
EPS (TTM):
$8.99
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $82.6B $78.7B $80B $85.2B $88.8B
Revenue Growth (YoY) 0.64% -4.66% 1.59% 6.46% 4.3%
 
Cost of Revenues $28.4B $23.4B $24.6B $26.6B $27.5B
Gross Profit $54.2B $55.3B $55.4B $58.6B $61.4B
Gross Profit Margin 65.58% 70.28% 69.25% 68.82% 69.07%
 
R&D Expenses $12.3B $14.3B $14.1B $15.1B $17.2B
Selling, General & Admin $22.1B $20.1B $20.2B $20.1B $22B
Other Inc / (Exp) -$3.1B -$1.6B -$1.9B -$8.8B -$6B
Operating Expenses $34.4B $34.4B $34.4B $35.2B $39.2B
Operating Income $19.7B $20.9B $21B $23.4B $22.1B
 
Net Interest Expenses $90M $130M -- -- --
EBT. Incl. Unusual Items $16.5B $19.2B $19.4B $15.1B $16.7B
Earnings of Discontinued Ops. -- $3.1B $1.6B $21.8B --
Income Tax Expense $1.8B $1.4B $3B $1.7B $2.6B
Net Income to Company $14.7B $20.9B $17.9B $35.2B $14.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $14.7B $20.9B $17.9B $35.2B $14.1B
 
Basic EPS (Cont. Ops) $5.59 $7.93 $6.83 $13.88 $5.84
Diluted EPS (Cont. Ops) $5.51 $7.81 $6.73 $13.72 $5.79
Weighted Average Basic Share $2.6B $2.6B $2.6B $2.5B $2.4B
Weighted Average Diluted Share $2.7B $2.7B $2.7B $2.6B $2.4B
 
EBITDA $23.9B $26.8B $26.6B $23.3B $24.8B
EBIT $16.7B $19.4B $19.6B $15.8B $17.4B
 
Revenue (Reported) $82.6B $78.7B $80B $85.2B $88.8B
Operating Income (Reported) $19.7B $20.9B $21B $23.4B $22.1B
Operating Income (Adjusted) $16.7B $19.4B $19.6B $15.8B $17.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $22.3B $23.4B $20.9B $21.4B $21.9B
Revenue Growth (YoY) 7.88% 4.95% -10.81% 2.34% 2.39%
 
Cost of Revenues $7.1B $7.6B $6.7B $6.5B $7.4B
Gross Profit $15.3B $15.8B $14.2B $14.9B $14.5B
Gross Profit Margin 68.36% 67.57% 68% 69.55% 66.4%
 
R&D Expenses $3.2B $4.1B $3.5B $3.5B $3.2B
Selling, General & Admin $5.2B $5.6B $4.5B $5.1B $5B
Other Inc / (Exp) $647M -$270M -$7.5B -$2.8B $7.2B
Operating Expenses $8.4B $9.7B $8B $8.6B $8.2B
Operating Income $6.8B $6.1B $6.2B $6.3B $6.3B
 
Net Interest Expenses $48M -- $14M -- --
EBT. Incl. Unusual Items $7.4B $5.9B -$1.3B $3.7B $13.6B
Earnings of Discontinued Ops. -- -- $423M -- --
Income Tax Expense $1.2B $713M -$796M $459M $2.6B
Net Income to Company $6.2B $5.1B -$68M $3.3B $11B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.2B $5.1B -$68M $3.3B $11B
 
Basic EPS (Cont. Ops) $2.35 $1.96 -$0.03 $1.35 $4.57
Diluted EPS (Cont. Ops) $2.32 $1.93 -$0.03 $1.34 $4.54
Weighted Average Basic Share $2.6B $2.6B $2.6B $2.4B $2.4B
Weighted Average Diluted Share $2.7B $2.7B $2.6B $2.4B $2.4B
 
EBITDA $9.4B $7.6B $805M $5.7B $15.6B
EBIT $7.5B $5.9B -$1.1B $3.9B $13.8B
 
Revenue (Reported) $22.3B $23.4B $20.9B $21.4B $21.9B
Operating Income (Reported) $6.8B $6.1B $6.2B $6.3B $6.3B
Operating Income (Adjusted) $7.5B $5.9B -$1.1B $3.9B $13.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $84.2B $79.8B $84.8B $85.6B $89.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $28.4B $23.9B $26.9B $26.4B $28.3B
Gross Profit $55.8B $55.9B $58B $59.3B $61B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $12.9B $15.2B $14.4B $15.2B $16.9B
Selling, General & Admin $22.2B $20.5B $21.3B $20.7B $22B
Other Inc / (Exp) -$3.2B -$2.6B -$8.9B -$4.1B $4B
Operating Expenses $35.2B $35.7B $35.7B $35.8B $38.9B
Operating Income $20.6B $20.2B $22.3B $23.4B $22.1B
 
Net Interest Expenses $180M $70M -- -- --
EBT. Incl. Unusual Items $17.4B $17.6B $13.6B $20.1B $26.6B
Earnings of Discontinued Ops. -- -- $864M $21.4B --
Income Tax Expense $2.3B $858M $1.7B $3B $4.8B
Net Income to Company $15.1B $19.8B $12.7B $38.5B $21.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $15.1B $19.8B $12.7B $38.5B $21.8B
 
Basic EPS (Cont. Ops) $5.74 $7.53 $4.85 $15.33 $9.07
Diluted EPS (Cont. Ops) $5.66 $7.42 $4.78 $15.18 $8.99
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $25B $25B $21.1B $28.2B $34.7B
EBIT $17.7B $17.7B $14B $20.8B $27.4B
 
Revenue (Reported) $84.2B $79.8B $84.8B $85.6B $89.3B
Operating Income (Reported) $20.6B $20.2B $22.3B $23.4B $22.1B
Operating Income (Adjusted) $17.7B $17.7B $14B $20.8B $27.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $22.3B $23.4B $20.9B $21.4B $21.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.1B $7.6B $6.7B $6.5B $7.4B
Gross Profit $15.3B $15.8B $14.2B $14.9B $14.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.2B $4.1B $3.5B $3.5B $3.2B
Selling, General & Admin $5.2B $5.6B $4.5B $5.1B $5B
Other Inc / (Exp) $647M -$270M -$7.5B -$2.8B $7.2B
Operating Expenses $8.4B $9.7B $8B $8.6B $8.2B
Operating Income $6.8B $6.1B $6.2B $6.3B $6.3B
 
Net Interest Expenses $48M -- $14M -- --
EBT. Incl. Unusual Items $7.4B $5.9B -$1.3B $3.7B $13.6B
Earnings of Discontinued Ops. -- -- $423M -- --
Income Tax Expense $1.2B $713M -$796M $459M $2.6B
Net Income to Company $6.2B $5.1B -$68M $3.3B $11B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.2B $5.1B -$68M $3.3B $11B
 
Basic EPS (Cont. Ops) $2.35 $1.96 -$0.03 $1.35 $4.57
Diluted EPS (Cont. Ops) $2.32 $1.93 -$0.03 $1.34 $4.54
Weighted Average Basic Share $2.6B $2.6B $2.6B $2.4B $2.4B
Weighted Average Diluted Share $2.7B $2.7B $2.6B $2.4B $2.4B
 
EBITDA $9.4B $7.6B $805M $5.7B $15.6B
EBIT $7.5B $5.9B -$1.1B $3.9B $13.8B
 
Revenue (Reported) $22.3B $23.4B $20.9B $21.4B $21.9B
Operating Income (Reported) $6.8B $6.1B $6.2B $6.3B $6.3B
Operating Income (Adjusted) $7.5B $5.9B -$1.1B $3.9B $13.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $14B $14.5B $12.9B $21.9B $24.1B
Short Term Investments $11.2B $17.1B $9.4B $1.1B $417M
Accounts Receivable, Net $13.6B $15.3B $14B $14.9B $14.8B
Inventory $9.3B $10.4B $10.3B $11.2B $12.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.1B -- -- -- --
Total Current Assets $51.2B $61B $55.3B $53.5B $55.9B
 
Property Plant And Equipment $18.8B $19B $18B $19.9B $20.5B
Long-Term Investments -- -- -- -- --
Goodwill $36.4B $35.2B $36B $36.6B $44.2B
Other Intangibles $53.4B $46.4B $38.5B $34.2B $37.6B
Other Long-Term Assets $6.6B $10.2B $30.6B $14.2B $11.4B
Total Assets $174.9B $182B $187.4B $167.6B $180.1B
 
Accounts Payable $9.5B $11.1B $9.9B $9.6B $10.3B
Accrued Expenses $25.5B $25.7B $24.3B $26.2B $26.1B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- $3.6B -- --
Total Current Liabilities $42.5B $45.2B $55.8B $46.3B $50.3B
 
Long-Term Debt $32.6B $30B $26.9B $25.9B $30.7B
Capital Leases -- -- -- -- --
Total Liabilities $111.6B $108B $110.6B $98.8B $108.6B
 
Common Stock $3.1B $3.1B $3.1B $3.1B $3.1B
Other Common Equity Adj -$15.2B -$13.1B -$13B -$12.5B -$11.7B
Common Equity $63.3B $74B $76.8B $68.8B $71.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $63.3B $74B $76.8B $68.8B $71.5B
 
Total Liabilities and Equity $174.9B $182B $187.4B $167.6B $180.1B
Cash and Short Terms $25.2B $31.6B $22.3B $22.9B $24.5B
Total Debt $35.3B $33.8B $39.6B $29.3B $36.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $12.7B $10.5B $19.2B $25.5B $38.5B
Short Term Investments $11.9B $19.9B $5.4B $745M $307M
Accounts Receivable, Net $14.9B $15.6B $16.4B $14.9B $16B
Inventory $10B $11B $12.8B $11.4B $12.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $3B $3.5B $2.9B $4.5B $4.1B
Total Current Assets $52.5B $60.4B $64.4B $57B $71.6B
 
Property Plant And Equipment $18.4B $18.7B $20.2B $19.6B $20.9B
Long-Term Investments -- -- -- -- --
Goodwill $35.7B $34.9B $45.6B $36.6B $44.5B
Other Intangibles $51.1B $44.4B $47.4B $34.3B $36.8B
Other Long-Term Assets $6.5B $9.9B $9.6B $14.1B $11.5B
Total Assets $172.6B $178.4B $196B $172B $193.7B
 
Accounts Payable $8.5B $9.3B $9.9B $8.2B $9.5B
Accrued Expenses $25.1B $26B $26B $26.5B $26.7B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $40.9B $43.4B $60.4B $48.7B $56.9B
 
Long-Term Debt $30.3B $28.9B $34.9B $25.1B $38.4B
Capital Leases -- -- -- -- --
Total Liabilities $106.7B $103.6B $125.1B $101.9B $115.6B
 
Common Stock $3.1B $3.1B $3.1B $3.1B $3.1B
Other Common Equity Adj -$15.3B -$13.8B -$12.6B -$10.8B -$11.7B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $65.8B $74.7B $70.9B $70B $78.1B
 
Total Liabilities and Equity $172.6B $178.4B $196B $172B $193.7B
Cash and Short Terms $24.6B $30.4B $24.6B $26.2B $38.8B
Total Debt $33.6B $33.1B $52.9B $33.6B $52.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $14.7B $20.9B $17.9B $35.2B $14.1B
Depreciation & Amoritzation $7.2B $7.4B $7B $7.5B $7.3B
Stock-Based Compensation $1B $1.1B $1.1B $1.2B $1.2B
Change in Accounts Receivable $774M -$2.4B -$1.3B -$624M -$406M
Change in Inventories -$265M -$1.2B -$2.5B -$1.3B -$1.1B
Cash From Operations $23.5B $23.4B $21.2B $22.8B $24.3B
 
Capital Expenditures $3.3B $3.7B $4B $5B $6.2B
Cash Acquisitions -$7.3B -$60M -$17.7B -- -$15.1B
Cash From Investing -$20.8B -$8.7B -$12.4B $878M -$18.6B
 
Dividends Paid (Ex Special Dividend) -$10.5B -$11B -$11.7B -$11.8B -$11.8B
Special Dividend Paid
Long-Term Debt Issued $10.8B $2B $16.1B $21.8B $21.9B
Long-Term Debt Repaid -$3.7B -$3B -$8.7B -$24.5B -$11.9B
Repurchase of Common Stock -$3.2B -$3.5B -$6B -$5.1B -$2.4B
Other Financing Activities -$627M $395M $65M -$1.6B $234M
Cash From Financing -$6.1B -$14B -$8.9B -$15.8B -$3.1B
 
Beginning Cash (CF) $17.3B $14B $14.5B $14.1B $21.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.4B $680M -$48M $7.8B $2.5B
Ending Cash (CF) $14B $14.5B $14.1B $21.9B $24.1B
 
Levered Free Cash Flow $20.2B $19.8B $17.2B $17.8B $18.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $6.2B $5.1B -$68M $3.3B $11B
Depreciation & Amoritzation $1.9B $1.8B $1.9B $1.8B $1.8B
Stock-Based Compensation $307M $278M $306M $302M $288M
Change in Accounts Receivable -$1.6B -$427M -$54M -$279M -$926M
Change in Inventories -$695M -$600M -$524M -$348M -$146M
Cash From Operations $4.1B $4B $3.3B $3.7B $4.2B
 
Capital Expenditures $677M $607M $863M $807M $809M
Cash Acquisitions -- -$252M -- -$1.8B --
Cash From Investing -$185M -$3.6B $3.3B -$464M -$297M
 
Dividends Paid (Ex Special Dividend) -$2.7B -$2.8B -$2.9B -$2.9B -$3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $24M $3B $18.8B $5.3B $17.9B
Long-Term Debt Repaid -$1.5B -$3B -$5.9B -$891M -$2.9B
Repurchase of Common Stock -$1.4B -$1.6B -$3.5B -$1.5B -$2.1B
Other Financing Activities $188M -$373M -$252M $321M $37M
Cash From Financing -$5.1B -$4.4B $6.1B $546M $10.4B
 
Beginning Cash (CF) $14B $14.5B $14.1B $21.9B $24.1B
Foreign Exchange Rate Adjustment -$78M $16M $28M -$125M $70M
Additions / Reductions -$1.2B -$4B $12.7B $3.7B $14.3B
Ending Cash (CF) $12.7B $10.5B $26.9B $25.5B $38.5B
 
Levered Free Cash Flow $3.4B $3.4B $2.4B $2.9B $3.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $15.1B $19.8B $12.7B $38.5B $21.8B
Depreciation & Amoritzation $7.4B $7.3B $7.1B $7.4B $7.3B
Stock-Based Compensation $1B $1.1B $1.2B $1.2B $1.2B
Change in Accounts Receivable -$18M -$1.2B -$917M -$849M -$1.1B
Change in Inventories -$801M -$1.2B -$2.5B -$1.1B -$926M
Cash From Operations $24.3B $23.3B $20.5B $23.2B $24.8B
 
Capital Expenditures $3.4B $3.6B $4.3B $5B $6.2B
Cash Acquisitions -$6.4B -$312M -$17.4B -$1.8B -$13.3B
Cash From Investing -$20.4B -$12.1B -$5.4B -$2.9B -$18.4B
 
Dividends Paid (Ex Special Dividend) -$10.6B -$11.2B -$11.8B -$11.7B -$11.9B
Special Dividend Paid
Long-Term Debt Issued $10.8B $5B $31.9B $8.3B $34.6B
Long-Term Debt Repaid -$5.2B -$4.5B -$11.6B -$19.5B -$13.9B
Repurchase of Common Stock -$2.9B -$3.6B -$8B -$3B -$3.1B
Other Financing Activities -$27M -$166M $186M -$1B -$50M
Cash From Financing -$6.9B -$13.3B $1.7B -$21.4B $6.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.1B -$2.1B $16.7B -$1.1B $13.1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $20.9B $19.7B $16.2B $18.2B $18.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $6.2B $5.1B -$68M $3.3B $11B
Depreciation & Amoritzation $1.9B $1.8B $1.9B $1.8B $1.8B
Stock-Based Compensation $307M $278M $306M $302M $288M
Change in Accounts Receivable -$1.6B -$427M -$54M -$279M -$926M
Change in Inventories -$695M -$600M -$524M -$348M -$146M
Cash From Operations $4.1B $4B $3.3B $3.7B $4.2B
 
Capital Expenditures $677M $607M $863M $807M $809M
Cash Acquisitions -- -$252M -- -$1.8B --
Cash From Investing -$185M -$3.6B $3.3B -$464M -$297M
 
Dividends Paid (Ex Special Dividend) -$2.7B -$2.8B -$2.9B -$2.9B -$3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $24M $3B $18.8B $5.3B $17.9B
Long-Term Debt Repaid -$1.5B -$3B -$5.9B -$891M -$2.9B
Repurchase of Common Stock -$1.4B -$1.6B -$3.5B -$1.5B -$2.1B
Other Financing Activities $188M -$373M -$252M $321M $37M
Cash From Financing -$5.1B -$4.4B $6.1B $546M $10.4B
 
Beginning Cash (CF) $14B $14.5B $14.1B $21.9B $24.1B
Foreign Exchange Rate Adjustment -$78M $16M $28M -$125M $70M
Additions / Reductions -$1.2B -$4B $12.7B $3.7B $14.3B
Ending Cash (CF) $12.7B $10.5B $26.9B $25.5B $38.5B
 
Levered Free Cash Flow $3.4B $3.4B $2.4B $2.9B $3.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Kestra Medical Stock Be in 1 Year?
Where Will Kestra Medical Stock Be in 1 Year?

Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…

Why Did Howard Marks Buy Grab Stock?
Why Did Howard Marks Buy Grab Stock?

When a legendary value investor who cut his teeth in…

Why Did Warren Buffett Buy Amazon Stock?
Why Did Warren Buffett Buy Amazon Stock?

When investors think of tech stocks in Warren Buffett’s portfolio,…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
88
CDTX alert for Jun 24

Cidara Therapeutics [CDTX] is up 3.18% over the past day.

Sell
46
HIMS alert for Jun 24

Hims & Hers Health [HIMS] is up 2.26% over the past day.

Buy
67
WGS alert for Jun 24

GeneDx Holdings [WGS] is up 13.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock